NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 2.2019-Reference-Cited by-同舟云学术

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 2.2019

Published:2019-09 Issue:9 Volume:17 Page:1032-1041
ISSN:1540-1405
Container-title:Journal of the National Comprehensive Cancer Network
language:
Short-container-title:

Author:

Gupta Samir¹,Provenzale Dawn²,Llor Xavier³,Halverson Amy L.⁴,Grady William⁵,Chung Daniel C.⁶,Haraldsdottir Sigurdis⁷,Markowitz Arnold J.⁸,Slavin Jr Thomas P.⁹,Hampel Heather,Ness Reid M.¹⁰,Weiss Jennifer M.¹¹,Ahnen Dennis J.¹²,Chen Lee-may¹³,Cooper Gregory¹⁴,Early Dayna S.¹⁵,Giardiello Francis M.¹⁶,Hall Michael J.¹⁷,Hamilton Stanley R.¹⁸,Kanth Priyanka¹⁹,Klapman Jason B.²⁰,Lazenby Audrey J.²¹,Lynch Patrick M.¹⁸,Mayer Robert J.²²,Mikkelson June,Peter Shajan²³,Regenbogen Scott E.²⁴,Dwyer Mary A.,Ogba Ndiya²⁵, , ,

Affiliation:

1. 1UC San Diego Moores Cancer Center;

2. 2Duke Cancer Institute;

3. 3Yale Cancer Center/Smilow Cancer Hospital;

4. 4Robert H. Lurie Comprehensive Cancer Center of Northwestern University;

5. 5Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance;

6. 6Massachusetts General Hospital Cancer Center;

7. 7Stanford Cancer Institute;

8. 8Memorial Sloan Kettering Cancer Center;

9. 9City of Hope National Medical Center;

10. 11Vanderbilt-Ingram Cancer Center;

11. 12University of Wisconsin Carbone Cancer Center;

12. 13University of Colorado Cancer Center;

13. 14UCSF Helen Diller Family Comprehensive Cancer Center;

14. 15Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute;

15. 16Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine;

16. 17The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins;

17. 18Fox Chase Cancer Center;

18. 19The University of Texas MD Anderson Cancer Center;

19. 20Huntsman Cancer Institute at the University of Utah;

20. 21Moffitt Cancer Center;

21. 22Fred & Pamela Buffett Cancer Center;

22. 23Dana-Farber/Brigham and Women’s Cancer Center;

23. 25O'Neal Comprehensive Cancer Center at UAB;

24. 26University of Michigan Rogel Cancer Center; and

25. 27National Comprehensive Cancer Network.

Abstract

Identifying individuals with hereditary syndromes allows for improved cancer surveillance, risk reduction, and optimized management. Establishing criteria for assessment allows for the identification of individuals who are carriers of pathogenic genetic variants. The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Colorectal provide recommendations for the assessment and management of patients with high-risk colorectal cancer syndromes. These NCCN Guidelines Insights focus on criteria for the evaluation of Lynch syndrome and considerations for use of multigene testing in the assessment of hereditary colorectal cancer syndromes.

Publisher

Harborside Press, LLC

Subject

Oncology

Cited by 184 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transarterial radioembolization and its impacts on colon cancer treatment and diagnosis;Colorectal Cancer;2024

2. Molecular and Clinicopathologic Characterization of Mismatch Repair-Deficient Endometrial Carcinoma Not Related to MLH1 Promoter Hypermethylation;Modern Pathology;2024-01

3. MRI grading for informed clinical decision-making in Peutz-Jeghers syndrome patients with cervical lesions;2023-12-04

4. Coordinated prospective follow-up of Lynch syndrome is able to detect the majority of incident cancers;Digestive and Liver Disease;2023-12

5. “Go ahead and screen” - advice to healthcare systems for routine lynch syndrome screening from interviews with newly diagnosed colorectal cancer patients;Hereditary Cancer in Clinical Practice;2023-11-17